Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-07 @ 1:09 PM
Study NCT ID:
NCT05242133
Status:
COMPLETED
Last Update Posted:
2022-10-18
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis
Sponsor:
Cinnagen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-17
First Submit QC Date:
None
Study First Post Date:
2022-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-16
Last Update Post Date:
2022-10-18
Last Update Post Date Type:
ACTUAL